The grant supports WashU’s Institute of Clinical and Translational Sciences.
ST. LOUIS — The University of Washington School of Medicine has received a $61 million federal grant to support the infrastructure needed to conduct biomedical research studies, officials said Thursday.
The grant, from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH), supports the Institute for Clinical and Translational Sciences (ICTS) at WashU.
The five-year grant, a renewal, enables ICTS to continue to serve as a “driver of innovation” in clinical and translational research in the region, with a focus on precision medicine, equity in health and diversity, officials said.
The ICTS, established in 2007, supports nearly 1,800 researchers from WashU and approximately 530 researchers from other regional institutions, including BJC HealthCare, Saint Louis University, University of Health Sciences and Pharmacy of St. Louis and the University of Missouri-Columbia.
WashU’s ICTS provides investigators with funding for staff, training, lab space, equipment and seed grants to help accelerate research discovery in the development of new therapies, officials said. .
“The most important work that our ICTS has done over the past five years has undoubtedly been our response to the Covid-19 pandemic,” said Dr. Guillaume PowderlyDirector of ICTS and Associate Dean for Clinical and Translational Research, said in a press release. “Through ICTS, we have the infrastructure that can allow translational science to flourish and, at the same time, position us to respond well to a national emergency caused by brand new infectious diseases.”
Read the rest of the story on the St. Louis Business Journal website.
Read more like this:
The former Café Natasha space will be a new restaurant and ba
Developer plans 1st dual-branded hotel in Metro East
Discover the interior of the new Le Méridien St. Louis Downtown hotel, with photos